| Names | |
|---|---|
|
Systematic IUPAC name
(2S)-2-[[2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]butanedioic acid
|
|
| Other names
L-Arginyl-Glycyl-L-Aspartic acid; Arg-Gly-Asp
|
|
| Identifiers | |
|
3D model (JSmol)
|
|
| Abbreviations | RGD Peptide |
| ChemSpider | |
| MeSH | arginyl-glycyl-aspartic+acid |
|
PubChem CID
|
|
|
|
|
|
| Properties | |
| C12H22N6O6 | |
| Molar mass | 346.34 g·mol−1 |
| log P | −3.016 |
| Acidity (pKa) | 2.851 |
| Basicity (pKb) | 11.146 |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
|
|
|
| Infobox references | |
Arginylglycylaspartic acid (RGD) is a tripeptide composed of L-arginine, glycine, and L-aspartic acid. The sequence is a common element in cellular recognition. Arginylglycylaspartic acid is used as a biochemical tool in the study of this recognition.
RGD-peptides are implicated in cellular attachment via integrins, and can be used to coat synthetic scaffolds in tissue engineering to enhance cellular attachment by mimicking in vivo conditions.